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A mammary-derived growth inhibitor (MDGI) inhibits the resumption of growth of stationary Ehrlich ascites carcinoma 
(EAC) cells in vitro. The present study shows that the resumption of growth is accompanied by a rapid increase of the 
steady state mRNA level of the proto-oncogenes c-fos, c-myc and c-ras, which is reduced by MDGI. EAC cells from 
the exponential growth phase insensitive to MDGI did not show a reduced RNA expression. The effect of MDGI repre- 
sents a novel activity at the level of gene expression and suggests a link to exist between growth inhibition and the reduc- 
tion of c-fos, c-myc and c-ras expression. 
Oncogene; Growth inhibitor; (Ehrlich ascites cell) 
1. INTRODUCTION 
Mammary-derived growth inhibitor (MDGI), 
isolated from bovine mammary glands, is a 
member of the small family of well defined growth 
inhibitors [l-3]. It inhibits the resumption of 
growth of EAC cells, taken from the stationary 
phase of growth in vivo, in a suspension culture. In 
contrast, EAC cells from the exponential phase of 
growth are not inhibited. The dependence of 
MDGI action on the growth state of the cells and 
on the presence of counteracting growth factors 
like EGF or insulin [4-61 suggests its involvement 
in the balance between positive and negative 
regulators mediating the regulation of cell pro- 
liferation. In the present study we investigated if 
the growth inhibition is reflected at the level of ex- 
pression of c-fos, c-myc and c-ras, oncogenes up- 
posed to be involved in growth regulation [7-91. 
2. MATERIALS AND METHODS 
2.1. Materials 
The following materials were obtained from the indicated 
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sources: pure mammary-derived growth inhibitor (self-prepared 
as described previously [3]); Bg/II-Sa/I fragment of v-fos from 
FBJ murine osteosarcoma virus cloned into EarnHI-Sa/I sites of 
pAT153 by substitution (kindly supplied by N. Teich, ICRF, 
England); EcoRI-EcoRI fragment of genomic DNA containing 
permuted provirus of avian myelocytomatosis virus, strain 
MC29, cloned into the EcoRI site of pBR313 (kindly supplied 
by M. Bishop, University of California, USA); BglI-Safl frag- 
ment of Harvey murine sarcoma virus cloned at the EcoRI site 
of pBR322 (kindly supplied by D.R. Lowy, NIH, USA); uridine 
5 ‘-[cu-“Pltriphosphate (spec. act. 800 Ci/mmol) (Radio- 
chemical Centre Amersham, England); nitrocellulose paper 
(Sartorius, FRG); pGEM plasmids (Promega Biotec, USA); 
restriction endonucleases (Boehringer Mannheim, FRG). 
2.2. Cell culture 
A hyperdiploid strain of the Ehrlich ascites mammary car- 
cinoma was used. The cells taken freshly from the peritoneal 
cavity of mice (exponentially growing cells 6 days, stationary 
cells 12 days after transplantation) were cultivated in suspension 
according to Negelein et al. [lo] as described in detail elsewhere 
[5]. Stationary cells are not proliferating but fully viable [l 1,121 
and resume growth after transplantation or in culture. After in- 
cubation of 15 x IO6 cells per sample (lo6 cells/ml medium 199 
supplemented with 4% calf serum) for the indicated times, cells 
were carefully washed with PBS and stored as a pellet in 
nitrogen up to RNA preparation. Aliquots had previously been 
transferred to the routine cell culture for measuring the increase 
in cell number after 24 h. Differences between duplicate 
samples were below 5% of the mean value, 
2.3. RNA preparation and analysis 
Total cellular RNA was isolated by the guanidinium isothio- 
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cyanate method described by Chomczynski and Sacchi [13]. 
RNA samples were quantified by measurement of 4280 and the 
purity was checked by measurement of 4~~0. For RNA slot 
analysis samples containing 1 or 3 pg RNA were transferred on- 
to a niti-ocellulose filter. 
The presence of c-fos, c-myc and c-ras RNA was probed us- 
ing radioactively labelled antisense RNA probes. To this end, a 
PsfI-Safi fragment (0.5 kb) of v-fos, a PsrI fragment (1.5 kb) 
of v-myc and an EcoRI fragment (0.4 kb) of c-ras were subclon- 
ed into the multicloning site of pGEM plasmids containing pro- 
moters for T7 and SP6 polymerases. 
The synthesis of labelled RNA using linearized plasmids was 
performed according to Melton et al. [14] using about 100 pCi 
[(u-“P]UTP per reaction and 30-60 units of T7-RNA- 
polymerase resulting in nearly 100% incorporation (162 ng, 
1.35 x lo9 dpm/pg RNA). 
The hybridization and wash procedures were done according 
to Church and Gilbert [15]. Autoradiography was done at 
-70°C for 2-5 h using intensifying screens. 
3. RESULTS 
Fig.1 presents slot blots of two RNA samples 
prepared in parallel from in vivo cells and il- 
lustrates their good agreement. However, we 
evaluated only differences estimated to be larger 
than 3-fold. In the experiments we preincubated 
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Fig. 1. Determination of c-fos, c-myc and c-ras gene expression 
in stationary EAC cells in vivo (2 parallel samples), after 2 h 
incubation of these cells in serum-free medium (0 min) and 
further incubation in serum-containing medium without MDGI 
(control, left slot) or with MDGI for 15, 60 and 120 min. 
the cells for 2 h in serum-free medium to accom- 
modate them to culture conditions. We then added 
serum after 2 h since all earlier experiments on 
growth inhibition by MDGI were also done with 
serum-containing medium. In the experiment 
shown in fig.1 we see a very strong increase of c- 
fos, c-myc and c-ras gene expression after 15 min 
and strong inhibition of this induction by MDGI. 
The fos and ras inductions were already abolished 
after 60 min whereas the myc induction seemed to 
be more stable and also partly recovered in MDGI- 
treated cells. Increase in cell number was 69% for 
the controls and 43% for the treated cells cor- 
responding to 38% inhibition which is well within 
the range of inhibition previously reported for 
MDGI [5,16]. A suppression of the induction was 
seen in each experiment even if the time course was 
not always the same. With EAC cells taken from 
the exponential growth phase in vivo and, 
therefore, highly proliferating and resistant to 
MDGI with regard to growth inhibition, MDGI 
did not suppress oncogene expression. In contrast, 
MDGI prevented the decrease of mRNA levels of 
c-fos and c-myc while an induction of ras is even 
strongly stimulated (fig.2). Increase in cell number 
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Fig.2. Determination of c-fos, c-myc and c-ras gene expression 
in EAC cells from the exponential growth state (viva) and after 
incubation in serum-containing medium with MDGI (MDGI) or 
without (control) for 15, 30, 60 and 120 min. 
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was 76% for controls and 75% for the treated 
cells. 
4. DISCUSSION 
All three oncogenes were present already in cells 
obtained from the stationary phase in vivo. This is 
in agreement with the demonstration of the 
presence of c-myc and c-fos in a c-DNA library of 
EAC cells in vivo [17]. In culture a strong induc- 
tion took place which is suppressed by MDGI. 
Though there were differences in the time course 
of the induction and its suppression, all three on- 
cogenes responded to MDGI. In rapidly pro- 
liferating cells, MDGI did not suppress oncogene 
induction but, in contrast, stabilized or increased 
it. Since these cells are also resistant o growth in- 
hibition by MDGI, the results suggest a link to ex- 
ist between growth suppression and oncogene 
induction. 
Compared to stimulating growth factors, much 
less is known about the existence and role of 
physiological growth inhibitors with the exception 
of interferon, tumor growth factor fl and tumor 
necrosis factor, all of which have been described to 
suppress c-fos, c-myc and/or c-ras expression 
[ 18-211. The present results show that an inhibitor 
which is neither structurally nor functionally 
related to these also has strong effects on oncogene 
expression. 
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